Growth Metrics

Protalix BioTherapeutics (PLX) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 428.57%
Dec 31, 2025 -333.33%
Sep 30, 2025 497.45%
Jun 30, 2025 110.04%
Mar 31, 2025 -155.56%
Dec 31, 2024 125.00%
Sep 30, 2024 233.33%
Jun 30, 2024 50.00%
Mar 31, 2024 40.00%
Dec 31, 2023 -233.33%
Sep 30, 2023 -110.34%
Jun 30, 2023 680.00%
Mar 31, 2023 28.57%
Dec 31, 2022 0.00%
Sep 30, 2022 36.36%
Jun 30, 2022 -120.00%
Mar 31, 2022 64.29%
Dec 31, 2021 -55.56%
Sep 30, 2021 64.00%
Jun 30, 2021 -78.57%
Mar 31, 2021 -566.67%
Dec 31, 2020 121.43%
Sep 30, 2020 -7.69%
Jun 30, 2020 -230.00%
Mar 31, 2020 400.00%
Dec 31, 2019 108.33%
Sep 30, 2019 53.85%
Jun 30, 2019 -4.00%
Mar 31, 2019 -25.00%
Dec 31, 2018 0.00%
Sep 30, 2018 33.33%
Jun 30, 2018 -20.00%
Mar 31, 2018 91.41%
Dec 31, 2017 -6,366.67%
Mar 31, 2017 -2,300.00%
Dec 31, 2016 71.43%
Sep 30, 2016 36.36%
Jun 30, 2016 -22.22%
Mar 31, 2016 -111.11%
Dec 31, 2015 2,125.00%
Sep 30, 2015 33.33%
Jun 30, 2015 0.00%
Mar 31, 2014 116.67%
Dec 31, 2013 -900.00%
Sep 30, 2013 185.71%
Jun 30, 2013 -240.00%
Mar 31, 2013 133.33%
Dec 31, 2012 -350.00%
Sep 30, 2012 -45.45%
Jun 30, 2012 57.14%
Mar 31, 2012 117.63%
Dec 31, 2011 -297.00%
Sep 30, 2011 37.50%
Jun 30, 2011 -366.67%
Mar 31, 2011 109.84%
Dec 31, 2010 -2,133.33%
Sep 30, 2010 -75.00%